A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas
Clinical trial NCT03632317 · WITHDRAWN
Trial details
- NCT number
- NCT03632317
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2025-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.